Fellowship · Charlotte, NC
Sponsored by Carolinas Medical Center
Exagamglogene Autotemcel for Severe Sickle Cell Disease.
The New England journal of medicine · 2024 · 351 citations · Lyndsay Molinari
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.
NEJM evidence · 2025 · 39 citations · Michael Kent
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 58 citations · Javier Oesterheld
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
The Lancet. Oncology · 2024 · 64 citations · David Gass
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.
Nature medicine · 2022 · 121 citations · David Gass
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.
Blood advances · 2024 · 31 citations · Ashley Hinson
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant.
Blood advances · 2021 · 74 citations · Jeffrey Huo
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · 18 citations · Ashley Hinson